Rayliant Wilshire NxtGen US Large Cap Equity ETF (RWLC) Stock Price

37.85 ▲ +0.66 (+1.77%)
Open: 37.61 Vol: 2.36K Day's range: 37.61 - 37.85 Nov 09, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
RWLC Technical Analysis
5 mins 30 mins Hourly Daily Weekly
NEUTRAL NEUTRAL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 37.59▲ 37.59▲ 37.52▲ 37.80▲ 38.20▼
MA10 37.49▲ 37.48▲ 37.85▼ 38.18▼ 38.56▼
MA20 38.00▼ 37.99▼ 38.20▼ 38.64▼ 38.35▼
MA50 38.67▼ 38.62▼ 38.64▼ 38.77▼ N/A    
MA100 38.66▼ 38.54▼ 38.43▼ 38.32▼ N/A    
MA200 37.72▲ 36.94▲ N/A     36.33▲ N/A    
  5 mins 30 mins Hourly Daily Weekly
MACD 0.008▲ 0.006▲ -0.055▼ -0.158▼ -0.358▼
RSI 43.969▼ 44.202▼ 42.902▼ 41.226▼ 51.846▲
STOCH 45.728     45.728     20.585     19.877▼ 50.102    
WILL %R -57.751     -57.751     -57.751     -68.125     -71.206    
CCI -1.236     -1.236     -24.003     -96.713     -163.531▼
Latest Filters Detected On RWLC
▲ RSI $RWLC RSI(14) Crossed Above 30 Set Alert
CDL $RWLC Marubozu Candlestick Pattern Detected Set Alert
Rayliant Wilshire NxtGen US Large Cap Equity ETF News
Rayliant NxtGen Multifactor US Equity ETF
Wednesday, November 04, 2026 10:40 AM
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
Libtayo® (cemiplimab-rwlc) Approved in the U.S. as First and Only Immunotherapy for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma (CSCC) with a High Risk of ...
Wednesday, October 08, 2025 11:31 AM
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
FDA approves Libtayo® (Cemiplimab-rwlc) as first immunotherapy indicated for patients with advanced basal cell carcinoma
Tuesday, February 09, 2021 09:15 AM
Following Priority Review Libtayo receives full approval in locally advanced basal cell carcinoma (BCC) and accelerated approval in metastic BCC Libtayo now approved for patients with advanced stages ...
RWLC historical stock data
date open high low close volume
09/11/26 37.61 37.85 37.61 37.85 2,358
06/11/26 37.22 37.3699 37.19 37.19 10,689
05/11/26 38.45 38.45 37.1201 37.125 9,093
04/11/26 38.699 38.74 38.65 38.65 2,791
03/11/26 38.08 38.27 38.07 38.165 1,912
02/11/26 38.585 38.585 38.25 38.25 2,277
30/10/26 38.50 38.50 38.22 38.22 6,028
29/10/26 38.675 38.675 38.575 38.575 16,356
28/10/26 38.8201 38.97 38.8201 38.89 1,316
27/10/26 38.735 38.915 38.735 38.8399 3,985
Quote Details
52wk Low:31.10
52wk High:39.655
Vol:2.36K
Avg Vol(3m):113.6K
1Y Chng:+0.00%
1M Chng:-1.69%
Add to Watch List
More Information
Sector N/A
Index N/A
Market Cap. 0.00